Rare Investment Opportunity: Peptides Ecommerce Business

Reaching out to share an exciting opportunity to partner on the acquisition and growth of Peptides, a leading global distributor in the high-growth research peptides market. With over 15 years in operation, the company has established itself as a market leader with exceptional financial performance and significant growth potential. Key Highlights: Enterprise Value: $250M. Revenue Growth: Increased from $15.7M in 2021 to $74M in 2023, with projected revenues exceeding $105M in 2024. EBITDA Margins: Consistently above 70%, with $80M projected EBITDA in 2024. Market Leadership: Top-ranked ecommerce platform for peptide-related keywords globally, serving over 100,000 loyal customers. Proposed Deal Structure: Requesting a Limited Partner Contribution: $120M as preferred equity with an 8%-10% annual return for 48% ownership Seller Financing: $120M over five years, secured by strong cash flows. General Partner Contribution and Ownership: $10M and consulting for 52% equity with owner financing to ensure operational alignment and growth through a five year exit. Growth Strategy: Product Innovation: Investment in next-generation peptides and customized solutions. Geographic Expansion: Targeting underpenetrated regions, including Europe, Canada, and the Middle East. Operational Efficiency: Scaling supply chain and production capabilities to meet rising global demand. Why This Opportunity? Peptides. is positioned for accelerated growth in a thriving $66.2B peptide therapeutics market projected by###-###-#### With strong cash flows, a loyal customer base, and significant room for expansion, this deal offers a compelling opportunity for attractive returns. I would welcome the opportunity to discuss this in more detail and share the comprehensive business plan.